A comparative study to compare laser and injection therapy vs injection treatment alone in treating keloids.
- Conditions
- Health Condition 1: L918- Other hypertrophic disorders of the skin
- Registration Number
- CTRI/2023/10/058276
- Lead Sponsor
- DrULavanya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
All clinically diagnosed cases of keloid .
Patients who are willing to give informed consent.
Before starting the study -
Patients who are pregnant or lactating.
Patients planning for pregnancy.
Patients with history of intake of oral retinoids in the past 6 months.
Patients with signs of active infection or lesions suspicious of malignancy.
Patients with diseases or genetic conditions causing photosensitivity or tending to aggravate after light exposure.
Patients with co-morbidities- DM,SHT,TB,CAD,EPILEPSY,BA.
Patients on Photosensitizing drugs,immunosuppressive drugs,anti coagulants.
Bleeding and coagulation disorders,HIV.
During Study -
If patient develops severe side effects like ulceration / intolerance to pain during the treatment.
If patient wants alternate treatment during the study.
If patient wants to discontinue the treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The end point will be the evaluation of clinical response to both the mode of treatment at 36 weeks after treatment initiation <br/ ><br>Responses in between the study will be noticed recorded using Modified Vancouver Scar Scale(MVSS) Physicians Global Assessment (PGA) scale Patients overall satisfaction scoreTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Safety profileTimepoint: 36 weeks